Evidence map›Paper›PMID 41783663›Full record

Observational studyJNMA; journal of the Nepal Medical Association2025

Antibiotic Susceptibility Profile of Carbapenem Resistant

Gaurav Verma, Shradha Smriti, Rajesh Kumar Dash, Liza Das, Dipti Pattnaik, Nipa Singh, Subhra Snigdha Panda, Sukanta Tripathy

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in JNMA; journal of the Nepal Medical Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gaurav VermaDepartment of Microbiology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Shradha SmritiDepartment of Microbiology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Rajesh Kumar DashDepartment of Microbiology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Liza DasDepartment of Microbiology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Dipti PattnaikDepartment of Microbiology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Nipa SinghDepartment of Microbiology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Subhra Snigdha PandaDepartment of Microbiology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Sukanta TripathyDepartment of Transfusion Medicine, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Urinary tract infections are common in both hospital and community settings and impose a significant financial burden. Among Enterobacterales, Methods: A prospective study was conducted from October 2023 to June 2024 in a tertiary care hospital in Eastern India. Urine samples received for routine culture in the central laboratory were processed following standard microbiological protocols. Bacterial identification and antibiotic susceptibility testing were performed using the VITEK-2 compact system. A total of 958 isolates of Results: Of the, 7228 urine samples, 4336 (60%) yielded a positive culture. Among these, 1552 (36%) were gram-negative bacteria. Out of the gramnegative bacteria, 1209 (77.8%) were Enterobacterales. Conclusions: Urinary tract infections caused by

Indexed as

Carbapenem-Resistant EnterobacteriaceaeCarbapenemsEscherichia coliEscherichia coli InfectionsKlebsiella InfectionsKlebsiella pneumoniaeUrinary Tract InfectionsAnti-Bacterial AgentsFosfomycinHumansIndiaMicrobial Sensitivity TestsProspective StudiesTertiary Care CentersAnti-Bacterial AgentsCarbapenemsFosfomycinantibiotic resistancecarbapenem resistancefosfomycinnitrofurantoinuropathogens

Identifiers

PMID41783663
PMCPMC12827863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.